澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BIO-GENE TECHNOLOGY LTD

0.018

-0.004-18.18%

成交量：24.44萬

成交額：5,259

市值：788.51萬

市盈率：-1.88

高：0.022

開：0.022

低：0.018

收：0.022

52周最高：0.061

52周最低：0.016

股本：4.38億

流通股本：1.68億

量比：13.92

換手率：0.15%

股息：- -

股息率：- -

每股收益(TTM):-0.010

每股收益(LYR):-0.012

淨資產收益率：-202.18%

總資產收益率：-94.90%

市淨率：6.76

市盈率(LYR):-1.47

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Bio-Gene Technology Ltd 通過配售及部分包銷購股計劃籌集321萬澳元

Bio-Gene Technology將擴大Flavocide與Qcide病媒控制產品在亞洲的評估範圍

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/BGT.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BGT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BGT.AU\",,,,,undefined,":{"symbol":"BGT.AU","market":"AU","secType":"STK","nameCN":"BIO-GENE TECHNOLOGY LTD","latestPrice":0.018,"timestamp":1786947120000,"preClose":0.022,"halted":0,"volume":244445,"delay":0,"changeRate":-0.18181818181818182,"nameEN":"BIO-GENE TECHNOLOGY LTD","floatShares":168118597,"shares":438061108,"eps":-0.009577,"marketStatus":"未開盤","change":-0.004,"latestTime":"08-17 16:12:00 AEST","open":0.022,"high":0.022,"low":0.018,"amount":5259,"amplitude":0.181818,"askPrice":0.022,"askSize":299429,"bidPrice":0.019,"bidSize":900000,"shortable":3,"etf":0,"ttmEps":-0.009577,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787011200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.022,"openAndCloseTimeList":[[1786924800000,1786946400000]],"volumeRatio":13.918022,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BGT.AU","preClose":0.022,"auctionPrice":0.022,"auctionVolume":670,"auction":3,"marketStatus":"盘后竞价","timestamp":1786946400966}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BGT.AU\",,,,,undefined,":{"symbol":"BGT.AU","floatShares":168118597,"roa":"-94.90%","roe":"-202.18%","lyrEps":-0.012234,"volumeRatio":13.918022,"shares":438061108,"dividePrice":0,"high":0.022,"amplitude":0.181818,"preClose":0.022,"low":0.018,"week52Low":0.016,"pbRate":"6.76","psRate":"20.19","week52High":0.061,"institutionHeld":0,"latestPrice":0.018,"committee":0.500714,"eps":-0.009577,"divideRate":0,"volume":244445,"delay":0,"ttmEps":-0.009577,"open":0.022,"prevYearClose":0.023,"prevWeekClose":0.022,"prevMonthClose":0.023,"prevQuarterClose":0.019,"fiveDayClose":0.022,"twentyDayClose":0.018,"sixtyDayClose":0.029},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGT.AU\",params:#limit:5,,,undefined,":[{"date":"2023-04-27","symbol":"BGT.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1682553600000,"name":null,"time":"","dateTimestamp":1682517600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGT.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196205410","title":"Bio-Gene Technology Ltd 通過配售及部分包銷購股計劃籌集321萬澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196205410","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196205410?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 09:24","pubTimestamp":1779758665,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd成功通过配售及部分包销的股票购买计划，筹集了总额321万澳元的资金。此次融资活动以每股0.025澳元的价格进行，共获得271万澳元的毛收益。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGT.AU","BK7020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111470522","title":"Bio-Gene Technology將擴大Flavocide與Qcide病媒控制產品在亞洲的評估範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=1111470522","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111470522?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 09:43","pubTimestamp":1779327824,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd宣布，将把其Flavocide与Qcide病媒控制产品的评估工作扩展至亚洲市场。此举标志着该公司在推广其创新病媒控制解决方案方面迈出了重要一步，旨在应对亚洲地区广泛的公共卫生挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGT.AU","BK7020"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BGT.AU\",params:#limit:6,delay:true,,,undefined,":[]}}